Braun Bostich & Associates Inc. Acquires New Position in Relx Plc (NYSE:RELX)

Braun Bostich & Associates Inc. acquired a new stake in Relx Plc (NYSE:RELX) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 3,985 shares of the technology company’s stock, valued at approximately $201,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. LGT Group Foundation purchased a new stake in shares of Relx during the fourth quarter worth $257,000. Paradigm Asset Management Co. LLC increased its position in Relx by 17.1% in the 4th quarter. Paradigm Asset Management Co. LLC now owns 81,600 shares of the technology company’s stock worth $3,706,000 after purchasing an additional 11,900 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Relx by 120.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 12,066 shares of the technology company’s stock worth $548,000 after purchasing an additional 6,588 shares in the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Relx by 21.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 162,830 shares of the technology company’s stock worth $7,396,000 after purchasing an additional 28,702 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Relx by 19.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 143,483 shares of the technology company’s stock valued at $6,517,000 after buying an additional 23,183 shares during the last quarter. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on RELX. Barclays upgraded Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. Morgan Stanley restated an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th. Finally, The Goldman Sachs Group started coverage on shares of Relx in a research note on Wednesday, March 26th. They issued a “buy” rating for the company. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy”.

Relx Stock Performance

RELX opened at $52.96 on Thursday. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The stock’s 50 day moving average price is $52.83 and its two-hundred day moving average price is $49.87. The firm has a market capitalization of $97.76 billion, a P/E ratio of 28.47, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.